檢索結果 - Gabi Tarcic

  • Showing 1 - 9 results of 9
Refine Results
  1. 1
    An Unbiased Screen Identifies DEP-1 Tumor Suppressor as a Phosphatase Controlling EGFR Endocytosis

    An Unbiased Screen Identifies DEP-1 Tumor Suppressor as a Phosphatase Controlling EGFR Endocytosis 由 Gabi Tarcic, Shlomit Boguslavsky, Jean Wakim, Tai Kiuchi, A.H. Liu, Felicia Reinitz, David Nathanson, Takamune Takahashi, Paul S. Mischel, Tony Ng, Yosef Yarden

    出版 2009
    獲取全文
    Artigo
    加到收藏夾
    Saved in:
  2. 2
    MHC Class I-Independent Recognition of NK-Activating Receptor KIR2DS4

    MHC Class I-Independent Recognition of NK-Activating Receptor KIR2DS4 由 Gil Katz, Roi Gazit, Tal I. Arnon, Tsufit Gonen‐Gross, Gabi Tarcic, Gal Markel, Raizy Gruda, Hagit Achdout, Olga Drize, Sharon Merims, Ofer Mandelboim

    出版 2004
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  3. 3
    Subclonal Therapy by Two EGFR TKIs Guided by Sequential Plasma Cell-free DNA in EGFR -Mutated Lung Cancer

    Subclonal Therapy by Two EGFR TKIs Guided by Sequential Plasma Cell-free DNA in EGFR -Mutated Lung Cancer 由 Nir Peled, Laila C. Roisman, Benjamin Miron, Raphael Pfeffer, Richard B. Lanman, Maya Ilouze, Addie Dvir, Lior Soussan‐Gutman, Fabrice Barlési, Gabi Tarcic, Oded Edelheit, David R. Gandara, Yehiel Elkabetz

    出版 2017
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  4. 4
    EGR1 and the ERK‐ERF axis drive mammary cell migration in response to EGF

    EGR1 and the ERK‐ERF axis drive mammary cell migration in response to EGF 由 Gabi Tarcic, Roi Avraham, Gur Pines, Ido Amit, Tal Shay, Yiling Lu, Yaara Zwang, Menachem Katz, Nir Ben‐Chetrit, Jasmine Jacob‐Hirsch, Laura Virgilio, Gideon Rechavi, George Mavrothalassitis, Gordon B. Mills, Eytan Domany, Yosef Yarden

    出版 2011
    獲取全文
    Artigo
    加到收藏夾
    Saved in:
  5. 5
    The histone H2B-specific ubiquitin ligase RNF20/hBRE1 acts as a putative tumor suppressor through selective regulation of gene expression

    The histone H2B-specific ubiquitin ligase RNF20/hBRE1 acts as a putative tumor suppressor through selective regulation of gene expression 由 Efrat Shema, Itay Tirosh, Yael Aylon, Jing Huang, Chaoyang Ye, Neta Moskovits, Nina Raver-Shapira, Neri Minsky, Judith Pirngruber, Gabi Tarcic, Pavla Hublarová, Lilach Moyal, Mali Gana‐Weisz, Yosef Shiloh, Yossef Yarden, Steven A. Johnsen, Bořivoj Vojtěšek, Shelley L. Berger, Moshe Oren

    出版 2008
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  6. 6
    SILAC identifies LAD1 as a filamin-binding regulator of actin dynamics in response to EGF and a marker of aggressive breast tumors

    SILAC identifies LAD1 as a filamin-binding regulator of actin dynamics in response to EGF and a marker of aggressive breast tumors 由 L. E. Roth, Swati Srivastava, Moshit Lindzen, Aldema Sas‐Chen, Michal Sheffer, Mattia Lauriola, Yehoshua Enuka, Ashish Noronha, Maicol Mancini, Sara Lavi, Gabi Tarcic, Gur Pines, Nava Nevo, Ori Heyman, Tamar Ziv, Oscar M. Rueda, Davide Gnocchi, Eli Pikarsky, Arie Admon, Carlos Caldas, Yosef Yarden

    出版 2018
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  7. 7
    Navigator‐3, a modulator of cell migration, may act as a suppressor of breast cancer progression

    Navigator‐3, a modulator of cell migration, may act as a suppressor of breast cancer progression 由 Hadas Cohen‐Dvashi, Nir Ben‐Chetrit, Roslin Russell, Sílvia Carvalho, Mattia Lauriola, Sophia Nisani, Maicol Mancini, Nishanth Belugali Nataraj, Merav Kedmi, L. E. Roth, Wolfgang J. Köstler, Amit Zeisel, Assif Yitzhaky, Jacques Zylberg, Gabi Tarcic, Raya Eilam, Yoav Wigelman, Rainer Will, Sara Lavi, Ziv Porat, Stefan Wiemann, Sara Ricardo, Fernando Schmitt, Carlos Caldas, Yosef Yarden

    出版 2015
    獲取全文
    Artigo
    加到收藏夾
    Saved in:
  8. 8
    Phase IB Study of Vemurafenib in Combination with Irinotecan and Cetuximab in Patients with Metastatic Colorectal Cancer with <i>BRAF</i>V600E Mutation

    Phase IB Study of Vemurafenib in Combination with Irinotecan and Cetuximab in Patients with Metastatic Colorectal Cancer with <i>BRAF</i>V600E Mutation 由 David S. Hong, Van K. Morris, Badi El Osta, Alexey V. Sorokin, Filip Janků, Siqing Fu, Michael J. Overman, Sarina A. Piha‐Paul, Vivek Subbiah, Bryan K. Kee, Apostolia M. Tsimberidou, David R. Fogelman, Jorge Bellido, Imad Shureiqi, Helen J. Huang, Johnique T. Atkins, Gabi Tarcic, Nicolas Sommer, Richard B. Lanman, Funda Meric‐Bernstam, Scott Kopetz

    出版 2016
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  9. 9
    Therapeutic implications of activating noncanonical PIK3CA mutations in head and neck squamous cell carcinoma

    Therapeutic implications of activating noncanonical PIK3CA mutations in head and neck squamous cell carcinoma 由 Nan Jin, Bhumsuk Keam, Janice Cho, Michelle J. Lee, Hye Ryun Kim, Hayarpi Torosyan, Natalia Jura, Patrick Kwok‐Shing Ng, Gordon B. Mills, Hua Li, Yan Zeng, Zohar Barbash, Gabi Tarcic, Hyunseok Kang, Julie E. Bauman, Mi‐Ok Kim, Nathan K. VanLandingham, Danielle L. Swaney, Nevan J. Krogan, Daniel E. Johnson, Jennifer R. Grandis

    出版 2021
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:

檢索工具: